Home / Resources / Videos / AACE 2018 / Tony Galliani Part 2, InPen Target Market

Tony Galliani Part 2, InPen Target Market




In part 2 of this Exclusive Interview, Tony Galliani talks with Diabetes in Control Publisher Steve Freed about their target market, patients who are not using insulin pumps.

Tony Galliani is the National Sales Director at Companion Medical located in San Diego.

Transcript of this video segment:

Freed: Who’s your target market?

Galliani: Target market is really anyone on intensive insulin therapy. We have talked about insulin pumps market before. The insulin pump market segment really isn’t growing that fast. And you look at maybe about 40% of type 1s are on insulin pumps, so our target would be the 60% that are not using pumps and that gives now patients visibility to what they’re doing and also gives the provider visibility to what the patient is doing. Because I think if you look at a patient on multiple daily injections, I don’t think I’ve met one yet that at some point has not forgotten to give a dose of insulin. So, now what they’re getting is if they don’t remember whether they gave their dose at breakfast, they can now just look at the home screen on their app and they can see not only when they dosed but how much they dosed. So, this gives them now that visibility to what they’re doing with their insulin delivery. And if they tend to forget to dose at meals, we also have reminders there that will remind them if they don’t have a dose.

Freed: Is there an alarm you can set, so that it can warn you not to take a dose or it’s time to take a dose?

Galliani: Yeah. You can set up timed reminders. So, let’s say you have someone that tends to forget to dose at lunch time, you can set a reminder — you set the time parameter. So, let’s say you would set the reminder between 11:45 and 12:15 if they don’t give a dose in that time, then the alarm will go off and remind them to give that dose.

Return to the main page.